Jaime A. Valderrama

Dr. Jaime A. Valderrama


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
JVJaime A. Valderrama
Jaime A. Valderrama
PCPamela Colonelli
Pamela Colonelli
David Reinaldo Vásquez VelásquezDavid Reinaldo Vásquez Velásquez
David Reinaldo Vásquez Velásquez
MGM. Florencia González
M. Florencia González
JRJaime A. Rodríguez
Jaime A. Rodríguez
CTCristina Theoduloz
Cristina Theoduloz

1 April 2009 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
JVJaime A. Valderrama
Jaime A. Valderrama
JIJ. Andrea Ibacache
J. Andrea Ibacache
VAVerónica Arancibia
Verónica Arancibia
JRJaime Rodriguez
Jaime Rodriguez
CTCristina Theoduloz
Cristina Theoduloz

1 July 2006 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
JVJaime A. Valderrama
Jaime A. Valderrama
MGM. Florencia González
M. Florencia González
CPCarlos David Pessoa-Mahana
Carlos David Pessoa-Mahana
RTRicardo Tapia
Ricardo Tapia
HFHouda Fillion
Houda Fillion
GSGuillermo Schmeda-Hirschmann
Guillermo Schmeda-Hirschmann

7 June 2012 in Molecules
Verified
Journal Article
Open access
PDF file
VDVirginia Delgado
Virginia Delgado
AIAndrea Ibacache
Andrea Ibacache
CTCristina Theoduloz
Cristina Theoduloz
JVJaime A. Valderrama
Jaime A. Valderrama
The synthesis of 4-methoxycarbonyl-3-methylisoquinolinequinone (1) and a variety of its substitution products with amino-, alkylamino and halogen groups on the quinone nucleus is reported. The series of 6-, 7- and 6,7-subtituted isoquinolinequinones were evaluated in vitro for their cytotoxic activity using the MTT colorimetric method. All the newly synthesized compounds showed moderate to high potency against MRC-5 healthy lung fibroblasts and four human tumor cell lines: AGS gastric adenocarcinoma, SK-MES-1 lung, J82 bladder carcinoma, and HL-60 leukemia cells. Among the series, compounds 4b, 12 and 13 exhibited interesting antitumor activity against human gastric adenocarcinoma, human lung and human bladder carcinoma cancer cells. 7-Amino-6-bromoisoquinoline-5,8-quinone (13) was found to be the most promising active compound against the tested cancer cell lines, with IC50 values in the 0.21−0.49 mM range, lower than the anti-cancer agent etoposide used as reference.

1 August 2011 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JVJaime A. Valderrama
Jaime A. Valderrama
AIAndrea Ibacache
Andrea Ibacache
JRJaime A. Rodriguez
Jaime A. Rodriguez
CTCristina Theoduloz
Cristina Theoduloz
JBJulio Benites
Julio Benites

1 April 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
JVJaime A. Valderrama
Jaime A. Valderrama
HLHilda Leiva
Hilda Leiva
JRJaime A. Rodríguez
Jaime A. Rodríguez
CTCristina Theoduloz
Cristina Theoduloz
GSGuillermo Schmeda-Hirschmann
Guillermo Schmeda-Hirschmann